Table 1.
Comparison of TTP between different groups
TTP median, h (IQR)a | p value | |
---|---|---|
Gender | ||
Female (104, 28%)b | 11.6 (9.6–13.0) | 0.34 |
Male (263, 72%) | 11.6 (9.9–14.3) | |
Age | ||
18–70 (112, 31%) | 11.7 (9.7–14.5) | 0.54 |
71–80 (135, 37%) | 11.7 (10.0–13.8) | |
81–96 (120, 33%) | 11.2 (9.7–13.8) | |
Charlson score | ||
0–2 (209, 60%) | 11.6 (10.0–14.1) | 0.15 |
3–4 (93, 25%) | 11.5 (9.4–13.4) | |
≥ 5 (65, 18%) | 12.3 (10.2–15.6) | |
Site of acquisition | ||
Community acquired (309, 84%) | 11.5 (9.6–13.9) | 0.043 |
Nosocomial (58, 16%) | 12.3 (10.7–14.3) | |
Focus of infection | ||
IE (55, 15%) | 9.4 (6.4–10.6) | < 0.001 |
Urinary tract (136, 37%) | 12.1 (10.6–14.4) | |
GI and biliary (29, %) | 12.4 (10.8–14.3) | |
Skin and soft tissue (28, 8%) | 12.1 (10.2–16.1) | |
Skeletal and joint (15, 4%) | 13.3 (11.5–20.7) | |
Other knownc (10, 3%) | 12.7 (9.7–15.4) | |
Unknown (94, 26%) | 11.7 (10.0–14.1) |
aInterquartile range
bNumber of episodes and the share of episodes are given within parenthesis
cPneumonia (n = 7) and other airway infections (n = 3)